Testing EGCG, folic acid, and vitamin B12 for HPV
Part of Infections clinical trials.
This trial tests whether taking a combination of EGCG (a compound from green tea), folic acid, and vitamin B12 can help prevent an HPV infection from lasting or getting worse. You may be able to join if you have a high-risk HPV infection but not a more serious cervical cell change called HSIL.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a positive test for a high-risk type of HPV.
- You must not have HSIL (high-grade squamous intraepithelial lesion), a more advanced cervical cell change.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a supplement containing green tea extract, folic acid, vitamin B12, and hyaluronic acid can help clear HPV from the cervix. It's for people with a low-grade cervical lesion who have had HPV for a while.
This study tests whether a dietary supplement containing EGCG, vitamin B12, hyaluronic acid, and folic acid helps men with an active HPV infection maintain a healthy reproductive system and immune defenses. It is for couples who are trying to get pregnant.
This study tests a new vaginal medication (Dysplasix) to treat mild cervical cell changes caused by high-risk HPV. The goal is to see if this treatment can help your body clear the virus and prevent these changes from getting worse.
This Phase 1 study tests FluBHPVE6E7, a new treatment designed to help the immune system respond to HPV16. It mainly checks safety and the best dose, and may help your body clear or control HPV over time.
This trial tests whether a dietary supplement with green tea extract, folic acid, vitamin B12, and hyaluronic acid can help men clear an active HPV infection while trying to conceive with their partner.
This trial tests whether an HPV vaccine (the nonavalent type) can help prevent the same precancerous lesions from coming back after treatment. It is for people who currently have a high-grade HPV-related lesion but have not yet been treated for it.
Hear when a new HPV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.